Advertisement

Topics

Companies Related to "Treatment Of Non-Tuberculous Mycobacterial Infections With Interferon Gamma" [Most Relevant Company Matches] [Advanced Search Results] RSS

22:09 EST 12th November 2018 | BioPortfolio

Here are the most relevant search results for "Treatment Of Non-Tuberculous Mycobacterial Infections With Interferon Gamma" found in our extensive corporate database of over 50,000 company records.

Showing "Treatment Tuberculous Mycobacterial Infections With Interferon Gamma" Companies 1–25 of 3,500+

Extremely Relevant

InterMune Pharmaceuticals

InterMune, Inc., is a biopharmaceutical company focused on developing and commercializing innovative therapies in hepatology and pulmonology. We market Actimmune® (interferon gamma-1b), approved for the treatment of severe, malignant osteopetrosis and chronic granulomatous disease. We have a late-stage and preclinical development pipeline in the areas of pulmonology and hepatology. In pulmono...


Interferon Sciences Incorporated

Interferon Sciences Incorporated is a biopharmaceutical company engaged in the study, manufacture, and sale of pharmaceutical products based on its highly purified, multispecies, natural source alpha interferon ("NaturalAlpha Interferon"). Interferon Sciences' ALFERON N Injection(R) (Interferon Alfa-n3) product has been approved by the United States Food and Drug Administration ("FDA...

Relevant

Connetics Corporation

Connetics Corporation is focused on the acquisition, development and commercialization of marketed and late-stageproducts. The Company's product and commercial focus is initially targeted at rheumatology and dermatology, two specialty medical markets. These commercially attractive markets have large patient populations yet relatively small physiciantreating groups. U.S. dermatologists and rheumato...


PBL Biomedical Laboratories

Our goal is to be your first source for interferons, interferon antibodies, interferon ELISA kits, and related products.anti-interferon antibodies

Amarillo Biosciences Incorporated

Amarillo Biosciences, Inc., (ABI), is a biopharmaceutical company developing low-dose oral and topical interferon alpha. We are directing our research at the treatment of Behcet's Disease, and oral warts in HIV+ patients and chronic cough in idiopathic pulmonary fibrosis. Low-dose oral interferon is Fundamentally Different from high dose injectable interferon. In this site, we will show the fun...

Gamma Knife Centre

Gamma Knife Surgery is a non-invasive method used for the treatment of arteriovenous malformations (AVMs), benign and malignant tumours of the brain. It does not involve traditional surgical incisions and thus devoid of post-operative complications with virtually no risk of mortality. There is no lengthy recuperation and most patients return to work within 2 to 3 days

Biogen Incorporated

Biogen, Inc. is a biopharmaceutical company principally engaged in the business of developing, manufacturing and marketing drugs for human health care. The Company currently derives revenues from sales of its AVONEX(R) (Interferon beta-1a) for the treatment of relapsing forms of multiple sclerosis and from sales by its licensees of a number of products, including alpha interferon, hepatitis B vacc...

Resolve Therapeutics, LLC

Resolve Therapeutics is a privately held biotechnology company based in Seattle that is dedicated to helping patients with lupus through the development of RSLV-125, its novel targeted biologic therapy. RSLV-125 represents a new approach to inhibiting the production of interferon-alpha at a proximal step in the inflammatory cascade. A multitude of evidence...

Gamma Labs

Gamma Labs, a division of Gamma Enterprises, LLC, is a company dedicated to supplying its customers with natural supplements which are based on the latest science and manufactured to the highest levels of pharmaceutical standards. Founded in 2004, Gamma Labs’ mission is to deliver proven, natural supplements which set up a foundation for peak performa...

GAMMA S.A.

Founded in 1983, GAMMA has privileged access to the University of Liège and is active in technology transfer from research laboratories to commercial applications. The company is specialized in immunological techniques for in vitro medical diagnostic use

Cell Medica Limited

Cell Medica is a cellular therapeutics company engaged in the development, manufacturing and marketing of T cell immunotherapy approaches for the treatment of infections and cancers related to oncogenic viruses. The Company’s lead cell product, CytovirTM CMV, for the treatment and prevention of cytomegalovirus (CMV) infections in patients following al...

ISICR

The International Society for Interferon and Cytokine Research (ISICR), based in Bethesda, Md., is a non-profit organization devoted to interferon, cytokine and chemokine research in the fields of cell biology, molecular biology, biochemistry, and pre-clinical and clinical drug development. The ISICR provides a forum for sharing knowledge and encourages ...

PBL InterferonSource

PBL InterferonSource, a division of Pestka Biomedical Laboratories based in Piscataway, N.J., USA, is the world’s leading supplier of interferon products to the life science researcher. Founded in 1990 by Dr. Sidney Pestka, PBL is the company that scientists turn to for their interferon-related needs: products, services, information, and know-how. The...

Gamma-Dynacare

Gamma-Dynacare is a partnership that was formed in the mid-1990s by the merging of the operations of three prominent Ontario medical diagnostic laboratories. We have built on our many years of combined experience to become one of the largest, most innovative and most responsive providers of laboratory services, information and products in Canada and enjoy a reputation for quality, service and flex...

GangaGen, Inc.

GangaGen, Inc. is a biotechnology company focused on the development of proprietary, bacteriophage-based products for the prevention and treatment of bacterial infections, particularly infections that are resistant to antibiotics, through the application of contemporary molecular and clinical sciences. The Company's bacteriophage, both natural and engineered, can be applied broadly to kill bacteri...

Gamma Medica, Inc. (USA)

Gamma Medica-Ideas designs, develops and manufactures next-generation imaging systems for both clinical and pre-clinical applications. The company invented MicroSPECT® and its X-SPECT® system is the market leader in the small animal SPECT category. Gamma Medica X-PET system has the highest sensitivity and largest axial field of view among small animal PET systems. The company X-O system is a sta...

Entasis Therapeutics Holdings Inc.

Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Entasis’ anti-infective discovery platform has produced a pipeline of meaningfully differentiated programs which target serious bacterial infections, including ETX2514SU...

Coridon Pty Ltd

Coridon is a privately held company headquartered in Brisbane Australia. The company was founded in 2000 for the purpose of developing DNA therapies for the prevention and treatment of viral infections such as Herpesvirus and Hepatitis C and therapeutic vaccines for the treatment of cancer.Our mission is to develop new DNA immunotherapies that achieve effective immune responses. These effective im...

Trius Therapeutics, Inc.

Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections. The company's first product candidate, torezolid phosphate, is an IV and orally administered second generation oxazolidinone being developed for the treatment of serious gram-positive infections, including those caused by ...

Appili Therapeutics Inc.

Appili is dedicated to identifying, acquiring and advancing novel therapeutics for infectious disease. The company has two anti-infective programs, ATI-1501 and ATI-1503, in its pipeline. ATI-1501 is a taste-masked treatment for anaerobic infections, including C. difficile. Appili’s second product, ATI-1503, is a novel antibiotic with broad potential ...

MicuRx Pharmaceuticals, Inc.

MicuRx is discovering and developing novel antibiotics to combat infections due to resistant bacteria. Positioned to capture the benefits of United States research and development expertise together with China's abundant scientific talent and cost-effective discovery, preclinical and development, the company has built a pipeline of drug candidates for the treatment of gram positive, gram negative ...

Basilea Pharmaceutica AG

Basilea Pharmaceutica AG is an independent biopharmaceutical company actively engaged in the discovery and development of innovative drugs for the treatment of bacterial infections, fungal infections and skin diseases associated with high unmet medical needs. Basilea focuses its resources and capabilities on the discovery, development and eventual marketing of innovative medicines. The company is ...

Tetraphase Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals is a clinical stage biopharmaceutical company utilizing its breakthrough synthetic chemistry technology platform to discover and develop next-generation tetracycline antibiotics that address unmet needs for serious infections such as drug resistance and gram-negative infections. The company has developed an emerging pipeline of p...

ZymoGenetics, Inc.

ZymoGenetics is a biopharmaceutical company focused on the development and commercialization of therapeutic proteins for the treatment of human diseases. The company has developed and is marketing RECOTHROM® Thrombin, topical (Recombinant) in the United States. ZymoGenetics has two product candidates in Phase 2 clinical development: PEG-Interferon lambd...

Sterigenics International LLC

Sterigenics International LLC is a global leader in outsourced contract sterilization services, gamma technologies and medical isotopes, and the only vertically integrated sterilization company in the world. Operating out of 43 facilities in 12 countries across the Americas, Europe and Asia, Sterigenics provides contract sterilization and ionization servic...


More From BioPortfolio on "Treatment Of Non-Tuberculous Mycobacterial Infections With Interferon Gamma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks